Cargando…
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
BACKGROUND AND AIMS: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns of SARS-Cov-2 in CLD patients, with or without cir...
Ejemplares similares
-
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2021) -
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19
por: Shiina, Shuichiro, et al.
Publicado: (2020) -
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2022) -
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
por: You, Hong, et al.
Publicado: (2022) -
Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia
por: Baatarkhuu, Oidov, et al.
Publicado: (2018)